QTc Prolongation and Ventricular Trigemini with Asenapine: A Case Report
Asenapine is one of the newer atypical antipsychotics on the market. It is a sublingually administered drug that is indicated for the treatment of both schizophrenia and bipolar disorder, and is considered to be safe and well tolerated. Herein, we report a 71-year-old female with a history of bipola...
| 主要な著者: | , |
|---|---|
| フォーマット: | 論文 |
| 出版事項: |
Turkish Association of Nervous and Mental Health
2017
|
| 主題: |